JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (11) Citing Articles via Google Scholar Google Scholar Articles by Kopman, A. F. Articles by Neuman, G. G. Search for Related Content PubMed PubMed Citation Articles by Kopman, A. F. Articles by Neuman, G. G. Related Collections Pharmacology

---

ANESTHETIC PHARMACOLOGY

Precurarization and Priming: A Theoretical Analysis of Safety and Timing

Department of Anesthesiology, Saint Vincents Hospital & Medical Center of New York, New York, New York

Address correspondence and reprint requests to Aaron F. Kopman, MD, Department of Anesthesiology (Room NR 408), St. Vincents Hospital & Medical Center, 170 W. 12th St., New York City, NY 10011. Address e-mail to akopman{at}rcn.com

The priming principle suggests that the onset of neuromuscular block may be accelerated if an intubating dose is preceded by a priming dose administered a few minutes earlier. We thought it would be instructive to use a pharmacodynamic/pharmacokinetic model to estimate the risk associated with different priming doses and intervals. In any normal population, there is wide variability in the response to neuromuscular blocking drugs. For most relaxants, the coefficient of variation for the 50% effective dose (ED₅₀) approximates 20%–25%. Thus, 1 patient in 50 (-2.05 SD) may have an ED₅₀ only half of the commonly cited value. By using published pharmacodynamic/pharmacokinetic data, we calculated the effect of administering 10%, 20%, or 30% of the ED₉₅ on the response of the adductor pollicis muscle in a population normally distributed with respect to drug sensitivity. A dose equivalent to 10% of the ED₉₅ will rarely produce a measurable neuromuscular effect. As this dose is increased, the potential for clinical weakness rapidly escalates. In 1 in 50 individuals, the usual recommendation of 10% of the intubation dose will produce measurable neuromuscular depression. For vecuronium, the optimal priming interval is 5 min. The safety and dependability of the priming principle is very much subject to the laws of probability.

IMPLICATIONS: When using the priming principle to accelerate the onset of neuromuscular block, the initial dose should not exceed 10% the drug’s ED₉₅. For drugs other than rocuronium, the optimal priming interval is not <5 min.

This article has been cited by other articles:

				M. Bock, L. Haselmann, B. W. Bottiger, and J. Motsch Priming with rocuronium accelerates neuromuscular block in children: a prospective randomized study: [L'amorcage avec le rocuronium accelere le bloc neuromusculaire chez les enfants : une etude prospective randomisee] Can J Anesth, July 1, 2007; 54(7): 538 - 543. [Abstract] [Full Text] [PDF]

				J. Schmidt, A. Irouschek, T. Muenster, T. M. Hemmerling, and S. Albrecht A priming technique accelerates onset of neuromuscular blockade at the laryngeal adductor muscles: [Une technique d'amorcage accelere le blocage neuromusculaire au niveau des muscles adducteurs du larynx] Can J Anesth, January 1, 2005; 52(1): 50 - 54. [Abstract] [Full Text] [PDF]

				T. Mencke, C. Becker, J. U. Schreiber, and T. Fuchs-Buder A longer pretreatment interval does not improve cisatracurium precurarization Can J Anesth, June 1, 2002; 49(6): 640 - 641. [Full Text]

Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999